Effect of lidoflazine on norepinephrine, angiotensin and serotonin responses in isolated smooth muscle preparations.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology*; D010879:Piperazines; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013270:Stomach; D014665:Vasodilator Agents / Q000494:pharmacology*
D010879:Piperazines; D012702:Serotonin Antagonists; D014665:Vasodilator Agents; D000804:Angiotensin II; D012701:Serotonin; D009638:Norepinephrine